Pimavanserin in Alzheimer’s Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms

被引：0
|
作者：
Clive Ballard
J. M. Youakim
B. Coate
S. Stankovic
机构：
[1] University of Exeter Medical School,Institute of Health Research
[2] ACADIA Pharmaceuticals Inc.,undefined
来源：
The Journal of Prevention of Alzheimer's Disease | 2019年 / 6卷
关键词：
Pimavanserin; Alzheimer’s disease; psychosis; severe;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：27 / 33
页数：6
相关论文
共 50 条
  • [21] Pimavanserin (Nuplazid) for Parkinson's Disease Psychosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2016, 58 (1496): : 74 - 75
  • [22] White matter changes associated with psychotic symptoms in Alzheimer's disease patients
    Lee, Dong Young
    Choo, Il Han
    Kim, Ki Woong
    Jhoo, Jin Hyeong
    Youn, Jong Choul
    Lee, Un Young
    Woo, Jong Inn
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2006, 18 (02) : 191 - 198
  • [23] Longterm efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia
    Street, J
    Clark, W
    Juliar, B
    Feldman, P
    Kadam, D
    Breier, A
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2000, 48 (08) : S80 - S80
  • [24] Pimavanserin as treatment for Parkinson's disease psychosis
    Fox, Susan H.
    LANCET, 2014, 383 (9916): : 494 - 496
  • [25] Efficacy of aripiprazole in highly agitated patients with psychosis of Alzheimer's disease
    Mintzer, JE
    Crandall, D
    Pultz, J
    Carson, W
    Gutierrez-Esteinou, R
    Whitehead, R
    Breader, C
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 128S - 129S
  • [26] Use of pimavanserin in patients with Parkinson's disease psychosis: Subgroup analysis of efficacy and safety in patients with and without cognitive impairment
    Weintraub, D.
    Norton, J.
    Coate, B.
    Andersson, C.
    Fredericks, D.
    Ballard, C.
    MOVEMENT DISORDERS, 2017, 32 (09) : E15 - E15
  • [27] Use of pimavanserin in patients with Parkinson's disease psychosis: subgroup analysis of efficacy and safety in patients with and without cognitive impairment
    Weintraub, D.
    Norton, J.
    Fredericks, D.
    Coate, B.
    Andersson, C.
    Ballard, C.
    MOVEMENT DISORDERS, 2017, 32
  • [28] Long term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia
    Street, JS
    Clark, WS
    Juliar, BE
    Feldman, PD
    Kadam, DL
    Breier, A
    NEUROLOGY, 2000, 54 (07) : A414 - A415
  • [29] Psychotic symptoms and physically aggressive behavior in Alzheimer's disease
    Gilley, DW
    Wilson, RS
    Beckett, LA
    Evans, DA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1997, 45 (09) : 1074 - 1079
  • [30] Prevalence and clinical correlates of psychotic symptoms in Alzheimer's disease
    Gormley, N
    Rizwan, MR
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1998, 13 (06) : 410 - 414
12345